155 related articles for article (PubMed ID: 38476014)
1. Identifying pregnancy episodes and estimating the last menstrual period using an administrative database in Korea: an application to patients with systemic lupus erythematosus.
Jung YS; Song YJ; Keum J; Lee JW; Jang EJ; Cho SK; Sung YK; Jung SY
Epidemiol Health; 2024; 46():e2024012. PubMed ID: 38476014
[TBL] [Abstract][Full Text] [Related]
2. Systemic lupus erythematosus and pregnancy: the challenge of improving antenatal care and outcomes.
Pastore DEA; Costa ML; Surita FG
Lupus; 2019 Oct; 28(12):1417-1426. PubMed ID: 31551036
[TBL] [Abstract][Full Text] [Related]
3. Comparative Rates of Serious Infections Among Patients With Systemic Lupus Erythematosus Receiving Immunosuppressive Medications.
Feldman CH; Marty FM; Winkelmayer WC; Guan H; Franklin JM; Solomon DH; Costenbader KH; Kim SC
Arthritis Rheumatol; 2017 Feb; 69(2):387-397. PubMed ID: 27589220
[TBL] [Abstract][Full Text] [Related]
4. Changes in immune cell frequencies after cyclophosphamide or mycophenolate mofetil treatments in patients with systemic lupus erythematosus.
Zhao L; Jiang Z; Jiang Y; Ma N; Wang K; Zhang Y
Clin Rheumatol; 2012 Jun; 31(6):951-9. PubMed ID: 22349930
[TBL] [Abstract][Full Text] [Related]
5. Reasons for cesarean and medically indicated deliveries in pregnancies in women with systemic lupus erythematosus.
Eudy AM; Jayasundara M; Haroun T; Neil L; James AH; Clowse MEB
Lupus; 2018 Mar; 27(3):351-356. PubMed ID: 28699378
[TBL] [Abstract][Full Text] [Related]
6. Fertility, ovarian failure, and pregnancy outcome in SLE patients treated with intravenous cyclophosphamide in Saudi Arabia.
Alarfaj AS; Khalil N
Clin Rheumatol; 2014 Dec; 33(12):1731-6. PubMed ID: 24894105
[TBL] [Abstract][Full Text] [Related]
7. A pharmacoeconomic study comparing the use of mycophenolate mofetil or cyclophosphamide as induction therapy in lupus nephritis patients in Egypt.
Khattab NM; Abbassi M; A Raafat H; Farid S
Lupus; 2022 Apr; 31(4):505-516. PubMed ID: 35254887
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of cyclophosphamide and mycophenolate mofetil on cellular and serological parameters in patients with systemic lupus erythematosus.
Fassbinder T; Saunders U; Mickholz E; Jung E; Becker H; Schlüter B; Jacobi AM
Arthritis Res Ther; 2015 Apr; 17(1):92. PubMed ID: 25890338
[TBL] [Abstract][Full Text] [Related]
9. Comparative risks of cardiovascular disease events among SLE patients receiving immunosuppressive medications.
Choi MY; Li D; Feldman CH; Yoshida K; Guan H; Kim SC; Everett BM; Costenbader KH
Rheumatology (Oxford); 2021 Aug; 60(8):3789-3798. PubMed ID: 33369672
[TBL] [Abstract][Full Text] [Related]
10. The effects of cyclophosphamide and mycophenolate on end-stage renal disease and death of lupus nephritis.
Koo HS; Kim YC; Lee SW; Kim DK; Oh KH; Joo KW; Kim YS; Ahn C; Han JS; Kim S; Chin HJ
Lupus; 2011 Nov; 20(13):1442-9. PubMed ID: 21951944
[TBL] [Abstract][Full Text] [Related]
11. Pregnancy in women with systemic lupus erythematosus: a retrospective study of 111 pregnancies in Chinese women.
Liu J; Zhao Y; Song Y; Zhang W; Bian X; Yang J; Liu D; Zeng X; Zhang F
J Matern Fetal Neonatal Med; 2012 Mar; 25(3):261-6. PubMed ID: 21504337
[TBL] [Abstract][Full Text] [Related]
12. Pregnancy outcomes in patients with systemic lupus erythematosus: a retrospective review of 62 pregnancies at a single tertiary center in South Korea.
Park EJ; Jung H; Hwang J; Kim H; Lee J; Ahn JK; Cha HS; Koh EM
Int J Rheum Dis; 2014 Nov; 17(8):887-97. PubMed ID: 25267089
[TBL] [Abstract][Full Text] [Related]
13. Immunosuppressive medication use and risk of herpes zoster (HZ) in patients with systemic lupus erythematosus (SLE): A nationwide case-control study.
Hu SC; Yen FL; Wang TN; Lin YC; Lin CL; Chen GS
J Am Acad Dermatol; 2016 Jul; 75(1):49-58. PubMed ID: 26946984
[TBL] [Abstract][Full Text] [Related]
14. The Effect of Mycophenolate Mofetil on Non-Renal Manifestations in Systemic Lupus Erythematosus: Results from Korean Lupus Network Registry.
Jung UH; Kwak SG; Choe JY; Lee SS; Kim SK
J Korean Med Sci; 2019 Jul; 34(27):e185. PubMed ID: 31293110
[TBL] [Abstract][Full Text] [Related]
15. Ovarian function is preserved in women with severe systemic lupus erythematosus after a 6-month course of cyclophosphamide followed by mycophenolate mofetil.
Laskari K; Zintzaras E; Tzioufas AG
Clin Exp Rheumatol; 2010; 28(1):83-6. PubMed ID: 20346244
[TBL] [Abstract][Full Text] [Related]
16. Azathioprine during pregnancy in systemic lupus erythematosus patients is not associated with poor fetal outcome.
Saavedra MÁ; Sánchez A; Morales S; Ángeles U; Jara LJ
Clin Rheumatol; 2015 Jul; 34(7):1211-6. PubMed ID: 26050103
[TBL] [Abstract][Full Text] [Related]
17. Pregnancy rates and perinatal outcomes in women with systemic lupus erythematosus: data from the Korean national health claims database.
Joo YB; Kim KJ; Park KS; Park YJ
Clin Rheumatol; 2021 Jun; 40(6):2243-2250. PubMed ID: 33184707
[TBL] [Abstract][Full Text] [Related]
18. Pregnancy outcome in women with systemic lupus erythematosus treated with immunosuppressive drugs.
Ramsey-Goldman R; Mientus JM; Kutzer JE; Mulvihill JJ; Medsger TA
J Rheumatol; 1993 Jul; 20(7):1152-7. PubMed ID: 8371208
[TBL] [Abstract][Full Text] [Related]
19. Pregnancy in patients with systemic lupus erythematosus after cyclophosphamide therapy.
Sen M; Kurl A; Khosroshahi A
Lupus; 2021 Aug; 30(9):1509-1514. PubMed ID: 34053364
[TBL] [Abstract][Full Text] [Related]
20. Mycophenolate mofetil for refractory haemolytic anemia in systemic lupus erythematosus.
Mak A; Mok CC
Lupus; 2005; 14(10):856-8. PubMed ID: 16302683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
